Dissection of the Mechanism of Obesity-induced Insullin Resistance

肥胖引起的胰岛素抵抗机制剖析

基本信息

  • 批准号:
    08457259
  • 负责人:
  • 金额:
    $ 4.93万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Insulin receptor subustrate-1(IRS-1) is the major substrate of insulin receptor and IGF-l receptor tyrosine kinases. Tyrosine-phosphorylated IRS-1 binds the 85K subunit of phosphatidylinositol 3-kinase which may be involved in the translocation of glucose transporters and the abundant src homology protein (ASH) / Grb2 which may be involved in activationn of p2l* and MAP kinase cascade. To clarify the physiological roles of IRS-1 in vivo, we made mice with a targeted disruption of the IRS-1 gene locus. Mice homozygous for targeted disruption of the IRS-I gene were born alive but were retarded in embryonal and postnatal growth. They also had resistance to the glucose-lowering effects of insulin. These data suggest the existence of both IRS-1-dependent and IRS-1-independent pathways for signal transduction of insulin and IGF_s (Tmemoto et al., Nature 372 : 182-186, 1994). We have examined the insulin-stimulated tyrosine-phosphorylated proteins in livers of wild type and IRS-1-deficient mi … More ce. Tyrosine phosphorylation of an 190-kDa protein (ppl9O) by insulin was significantly stimulated in livers of IRS-1-deftcient mice, which was weakly observed in wild type mice in addition to IRS-1. We also demonstrated that pp190 was immunologically distinct from IRS-1 and was associated with both the 85-kDa subunit of phosphatidylinositol 3-kinase and the Grb2/Ash molecule as IRS-1. We identified pp190 as a novel substrate for insulin receptor kinase (IRS-2), which can bind both PI3-kinase and Ash/Grb2, and whose tyrosine phosphorylation is specifically induced in IRS-1-deficient mice. These data suggested that pp19O may play some physiological roles in insulin's signal transduction ; furthermore, induction of tyrosine phosphorylation of pp19O may be one of the compensatory mechanisms that substitute for IRS-1 in IRS-1-deficient mice (Tobe et al., I.Biob Chem. 270 : 5698-5701, 1995). We further investigated the roles of IRS-1 and IRS-2 in the biological actions in the physiological target organs of insulin by comparing the effects of insulin in wild-type and IRS-1-deficient mice. In muscles from IRS-1-deficient mice, the responses to insulin-induced P13-kinase activation, glucose transport, p70 S6 kinase and MAP kinase activation. mRNA translation, and protein synthesis were significantly impaired compared with those in wild-type mice. Insulin-induced protein synthesis was both wortmannin sensitive and insensitive in wild-type and IRS-I-deficient mice. However, in another target organ, the liver, the responses to insulin-induced P13-kinase and MAP kinase activation were not significantly reduced. The amount of tyrosine-phosphorylated IRS-2 (in IRS-1-deficient mice) was roughly equal to that of IRS-1 (in wild-type mice) in the liver, whereas it was only 20 to 30% of that of IRS-1 in the muscles. In counclusion, (i) IRS-1 plays central roles in two major biological actions of insulin in muscles, glucose transport and protein synthesis ; (ii) the insulin resistance Less
胰岛素受体亚基-1(IRS-1)是胰岛素受体和IGF-1受体酪氨酸激酶的主要底物。酪氨酸磷酸化的IRS-1与参与葡萄糖转运蛋白转位的磷脂酰肌醇3-激酶85 K亚基和参与p2 l * 和MAP激酶级联反应的src同源蛋白(ASH)/Grb 2结合。为了阐明IRS-1在体内的生理作用,我们制作了具有IRS-1基因位点靶向破坏的小鼠。IRS-I基因靶向破坏的纯合子小鼠出生时存活,但胚胎和出生后生长迟缓。他们也对胰岛素的降糖作用有抵抗力。这些数据表明胰岛素和IGF_s的信号转导存在IRS-1依赖性和IRS-1非依赖性途径(Tmemoto等人,Nature 372:182-186,1994)。我们检测了野生型和IRS-1缺陷型小鼠肝脏中胰岛素刺激的酪氨酸磷酸化蛋白, ...更多信息 ce.在IRS-1缺陷小鼠的肝脏中,胰岛素对190-kDa蛋白质(ppl 90)的酪氨酸磷酸化显著刺激,这在野生型小鼠中除了IRS-1外观察到微弱。我们还证明pp 190在免疫学上与IRS-1不同,并且与磷脂酰肌醇3-激酶的85-kDa亚基和IRS-1的Grb 2/Ash分子相关。我们确定pp 190作为胰岛素受体激酶(IRS-2)的一种新型底物,它可以结合PI 3-激酶和Ash/Grb 2,并且其酪氨酸磷酸化在IRS-1缺陷小鼠中特异性诱导。这些数据表明,pp 19 O可能在胰岛素的信号转导中发挥某些生理作用;此外,pp 19 O的酪氨酸磷酸化的诱导可能是IRS-1缺陷小鼠中替代IRS-1的代偿机制之一(Tobe et al.,270:5698-5701,1995)。我们进一步研究了IRS-1和IRS-2在胰岛素生理靶器官的生物学作用中的作用,通过比较胰岛素在野生型和IRS-1缺陷小鼠中的作用。在IRS-1缺陷小鼠的肌肉中,对胰岛素诱导的P13激酶激活、葡萄糖转运、p70 S6激酶和MAP激酶激活的反应。与野生型小鼠相比,mRNA翻译和蛋白质合成显著受损。在野生型和IRS-I缺陷小鼠中,胰岛素诱导的蛋白质合成对渥曼青霉素既敏感又不敏感。然而,在另一个靶器官,肝脏,胰岛素诱导的P13激酶和MAP激酶激活的反应没有显着降低。在肝脏中,酪氨酸磷酸化的IRS-2(IRS-1缺陷小鼠)的量与IRS-1(野生型小鼠)的量大致相等,而肌肉中的IRS-2的量仅为IRS-1的20%至30%。结论:(i)IRS-1在胰岛素在肌肉中的两个主要生物学作用,即葡萄糖转运和蛋白质合成中起着中心作用;(ii)胰岛素抵抗

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamamoto-Honda, R., et al: "Upstream mechanisms of glycogen synthase activation by insulinand insulin-like growth factor-I." J.Biol.Chem.270. 2729-2374 (1995)
Yamamoto-Honda, R. 等人:“胰岛素和胰岛素样生长因子-I 激活糖原合酶的上游机制。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tobe,K.: "Protein kinase B (c-Akt) regulates glucose transport,glycogen synthesis and protein synthesis by insulin." J.Biol.Chem.(in press). (1997)
Tobe, K.:“蛋白激酶 B (c-Akt) 通过胰岛素调节葡萄糖转运、糖原合成和蛋白质合成。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kaburagi, Y., et al: "Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose trasport and GLUT4 translocation in primary adipocytes." J.Biol.Chem.272. 25839-25844 (1997)
Kaburagi, Y. 等人:“胰岛素受体底物 1 和 pp60 在调节原代脂肪细胞中胰岛素诱导的葡萄糖转运和 GLUT4 易位中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ueki, K., et al: "Protein kinase B (c-Akt) regulates glucose transport, glycogen synthesis and protein syntesis by insulin." J.Biol.Chem.273. 5315-22 (1998)
Ueki, K. 等人:“蛋白激酶 B (c-Akt) 通过胰岛素调节葡萄糖转运、糖原合成和蛋白质合成。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tobe,K.: "Insulin resistance and growth retardation in mice lacking insulin receptor substratc-1" Nature. 372. 182-186 (1994)
Tobe,K.:“缺乏胰岛素受体 substratc-1 的小鼠的胰岛素抵抗和生长迟缓”自然。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOBE Kazuyuki其他文献

TOBE Kazuyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOBE Kazuyuki', 18)}}的其他基金

The role of M2-like macrophages in glucose metabolism
M2样巨噬细胞在葡萄糖代谢中的作用
  • 批准号:
    26461327
  • 财政年份:
    2014
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of insulin resistance by adipose tissue M1/M2 macrophages.
脂肪组织 M1/M2 巨噬细胞对胰岛素抵抗的调节。
  • 批准号:
    21591126
  • 财政年份:
    2009
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dissection of the role of IRS family proteins in the growth and development of pancreatic β cells
解析IRS家族蛋白在胰腺β细胞生长发育中的作用
  • 批准号:
    17390261
  • 财政年份:
    2005
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of insulin resistance and strategy of treatment
胰岛素抵抗机制及治疗策略
  • 批准号:
    15390284
  • 财政年份:
    2003
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dissection of the Mechanism of Diabetes by Genetically Engineered Animals
基因工程动物剖析糖尿病机制
  • 批准号:
    13470224
  • 财政年份:
    2001
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
PPARγ antagonist ameliorates obesity, insulin resistance and atherosclerosis.
PPARγ 拮抗剂可改善肥胖、胰岛素抵抗和动脉粥样硬化。
  • 批准号:
    13557092
  • 财政年份:
    2001
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dissection of the Mechanism of Insulin Resistance by Transgenic and knockout Mice Technology
通过转基因和基因敲除小鼠技术剖析胰岛素抵抗机制
  • 批准号:
    10470229
  • 财政年份:
    1998
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Dissection of the Mechanism of Obesity-induced Insulin Resistance
肥胖引起的胰岛素抵抗机制剖析
  • 批准号:
    09557077
  • 财政年份:
    1997
  • 资助金额:
    $ 4.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了